Type-1 transforming growth factor-beta differentially modulates tumoricidal activity of murine peritoneal macrophages against metastatic variants of the B16 murine melanoma

Journal of Experimental Therapeutics and Oncology

Volumn 2, Issue 5, 2002, Pages 286-297

  Fan, Dominic ^a   Liaw, Amy ^a   Denkins, Yvonne M ^a   Collins, James H ^a   Van Arsdall, Melissa ^a   Lien Chang, Jolie ^a   Chakrabarty, Subhas ^a   Nguyen, Dieuthu ^a   Kruzel, Ewa ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

B16 melanoma; Macrophages; Metastatic potential; TGF 1; Tumoricidal activity

Indexed keywords

RECOMBINANT GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG TARGETING; MACROPHAGE ACTIVATION; MELANOMA B16; METASTASIS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TARGET CELL;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; LIPOSOMES; MACROPHAGES, PERITONEAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 18544372087     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1359-4117.2002.01053.x     Document Type: Article

References (63)

1. Transforming growth factor-β: Biological function and chemical structure
2. Some recent advances in the chemistry and biology of transforming growth factor-beta
3. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells
4. Increased secretion of type beta transforming growth factor accompanies viral transformation of cells
5. Transforming growth factor production by chemically transformed cells
6. New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues
7. Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor
8. Clonal stimulation or inhibition of human colon carcinomas and human renal carcinomas mediated by transforming growth factor-β 1
9. Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor β1 and β 2
10. Stimulation of glycolysis and amino acid uptake in NRK-49F cells by transforming growth factor β and epidermal growth factor
11. Stimulation of glucose uptake by transforming growth factor β: Evidence for the requirement of epidermal growth factor-receptor activation
12. α β human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria
13. Transforming growth factor-beta-induced osteoblast elongation regulates osteoclastic bone resorption through a p38 mitogen-activated protein kinase- and matrix metalloproteinase-dependent pathway
14. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
15. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
16. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-β
17. Transient inhibition of liver regeneration in mice by transforming growth factor-β 1 encapsulated in liposomes
18. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells
19. Anchorage-independent growth of primary rat embryo cells is induced by platelet-derived growth factor and inhibited by type-beta transforming growth factor
20. Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis
21. Transforming growth factor-beta 1 increases internalization of basic fibroblast growth factor by smooth muscle cells: Implication of cell-surface heparan sulphate proteoglycan endocytosis
22. Deactivation of macrophages by transforming growth factor-β
23. Effects of transforming growth factor beta on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness
24. Inhibition of cytolytic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha
25. Transforming growth factor inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells
26. Transforming growth factor beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokines-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1
27. Distinct mechanisms of inhibition of interleukin-6-induced Stat3 signaling by TGF-beta and alpha-thrombin in CCL 39 cells
28. TNF-alpha and TGF-beta act synergistically to kill Schwann cells
29. Effects of type I/type II interferons and transforming growth factor-beta on B-cell differentiation and proliferation. Definition of costimulation and cytokine requirements for immunoglobulin synthesis and expression
30. Expression of PDGF receptors and ligand-induced migration of partially differentiated human monocyte-derived macrophages. Influence of IFN-gamma and TGF-beta
31. Selection of successive tumor lines for metastasis
32. The selection and characterization of an invasive variant of the B16 melanoma
33. Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines
34. Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or meninges of syngeneic animals
35. The effects of experimental conditions on the expression of in vitro mediated tumor cytotoxicity mediated by murine macrophages
36. Antiproliferative activity of liposome-encapsulated transforming growth factor-β against MDA-MB-435 human breast carcinoma cells
37. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: In situ activation of macrophages and therapy of spontaneous cancer metastases
38. Characterization of liposomes containing the chemotactic peptide N-formyl-methionyl-leucylphenylalanine (FMLP) and their interaction with mouse macrophages
39. Enhancement of tumor cell sensitivity to Adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine liposomes
40. Synergistic activation by recombinant mouse interferon-γ and muramyl dipeptide of tumoricidal properties in mouse macrophages
41. Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions
42. Inactive secreted form(s) of transforming growth factor-beta: Activation by proteolysis
43. pH distribution in human tumors
44. Cancer metastasis: Organ colonization and the cell surface properties of malignant cells
45. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis
46. Role of collagenases in tumor cell invasion
47. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling
48. Type-beta transforming growth factor in human platelets: Release during platelet degranulation and action on vascular smooth muscle cells
49. Transforming growth factor-beta signaling through the Smad pathway: Role in extracellular matrix gene expression and regulation
50. Transforming growth-factor beta (TGF-beta) induces monocyte chemotaxis and growth factor production
51. Macrophages and metastasis - A biological approach to cancer therapy
52. Characterization of the inhibitory effects of transforming growth factor-β on a human colon carcinoma cell line
53. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta
54. Opposite and selective effects of epidermal growth factor and human platelet transforming growth factor-beta on the production of selected proteins by murine 3T3 cells and human fibroblasts
55. Isolation of the oncogene and epidermal growth factor-induced transin gene: Complex control in rat fibroblasts
56. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta
57. Transforming growth factor type-beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
58. Deactivation of macrophages by transforming growth factor-β
59. Expression and secretion of type beta transforming growth factor by activated human macrophages
60. Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions
61. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes
62. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages
63. Distribution and fate of free and liposome-encapsulated ′3H:nor-muramyl dipeptide and ′3H:muramyl tripeptide phosphatidylethanolamine in mice